Lauren Biscaldi, MS, Managing Editor

CBD therapy has had positive outcomes in other inflammatory conditions.

Results of multiple studies were presented at IDWeek 2022.

Investigators reviewed data from 19 studies and 11 consecutive flu seasons.

The US was the first country to begin universal vaccination of children against varicella.

Moderna’s bivalent mRNA COVID-19 booster reached prespecified superiority and noninferiority criteria against multiple strains of SARS-CoV-2.

A selection of the latest COVID-19 vaccine research out of IDWeek 2022.

Guidelines for prescribing antibiotics in the dental setting should be revisited.

Viral coinfections may become more common as COVID-19 restrictions continue to relax.

IDWeek is taking place in person for the first time in 3 years.

SingleCare's 4th annual celebration of the best in pharmacy, from pharmacists to pharmacy technicians and teams across the United States has been announced.

The winner was announced during the first General Session of the 2022 NCPA Annual Convention

Take in these top tips for pharmacy front-end management.

MyRx AI Pricing uses enhanced analytics to bring dynamic pricing to pharmacies and cash-paying customers.

Data from periods of Delta and Omicron variant predominance were evaluated in a retrospective cohort study.

Tune in on Saturday, October 22, 2022.

The meeting will take place in Kansas City, Missouri, from October 1 through October 4.

Continued advocacy work is the key to seeing state and federal legislative action come to fruition.

These bivalent formulations include an mRNA component common to the BA.4 and BA.5 Omicron variant.

The vaccine was previously authorized under an EUA for adults aged 18 and older.

The latest guidance for when to administer the COVID-19 vaccine to patients aged 6 months and older.

Technology can help manage every aspect of the pharmacy.

Drug Topics® sat down with Bob Katter to discuss what FDB Vela brings to the table to improve the prescribing process, particularly with specialty medications.

The relationship between Bright Plaza Pharmacy and their AmerisourceBergen business coach has proved invaluable during the pandemic and beyond.

The decision comes following reports of 16,000 cases across 75 countries and territories around the world.

The Drug Topics® team is on the ground at ThoughtSpot 2022. Here's what you missed on Day 1.

After 40 years of experience, Good Neighbor Pharmacy is ready to tackle whatever challenges lie ahead for independent pharmacies.

Adults aged 18 and older are eligible to receive the vaccine.

The approval represents an adjunctive therapy option for adults and pediatric patients older than age 16.